Avellino Lab USA, Inc. announced a strategic partnership with Sugentech Inc. to scale up the supply of tests designed to detect COVID-19 in the United States. The Sugentech testing technologies complement Avellino’s current EUA authorized RT-PCR test in the US, the AvellinoCoV2 test. Under the terms of the agreement, Avellino will distribute Sugentech’s COVID-19 rapid diagnostic serology test. Avellino will also commercialize Sugentech’s quantitative viral neutralization, enzyme-linked immunosorbent assay (ELISA) to determine the presence of protective antibodies against COVID-19.